NEOGENOMICS INC (NEO) › Operating IncomeNEOGENOMICS INC (NEO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$2.96M2011: -$409.0K2012: $1.21M2013: $3.17M2014: $2.22M2015: -$5.63M2016: $2.15M2017: $2.90M2018: $10.04M2019: $13.01M2020: -$13.99M2021: -$118.75M2022: -$157.62M2023: -$107.74M2024: -$92.11M2025: -$115.88M-$115.88M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$115.88M-25.8%2024-$92.11M+14.5%2023-$107.74M+31.6%2022-$157.62M-32.7%2021-$118.75M-748.7%2020-$13.99M-207.6%2019$13.01M+29.5%2018$10.04M+246.0%2017$2.90M+34.7%2016$2.15M+138.2%2015-$5.63M-354.1%2014$2.22M-30.1%2013$3.17M+162.1%2012$1.21M+396.1%2011-$409.0K+86.2%2010-$2.96M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share